Open Accessibility Menu

Coronavirus (COVID-19) Update - We are open with your safety in mind. Click here to learn more.

For information about COVID-19, the vaccine, or to view additional resources, please click here.

Patient Education

gw dermatology patient education resources

At GW Dermatology, we offer a full range of dermatology services for adults with skin conditions as common as warts and as complicated as skin cancer. Our goal is to provide each patient with the best care possible, whether we are treating acne or a skin condition including but not limited to:


Acne is a skin condition caused by changes to the oil glands which surround hair follicles. The associated pimples may surface more commonly on the face, but may also affect the chest and back.

Acne occurs most commonly during the teenage years, but frequently continues into adulthood. For most people, acne diminishes over time and tends to disappear during the early twenties. Some people will continue to suffer well into their thirties, forties and beyond.

Acne can be treated with oral medications, topical creams, laser therapies like Isolaz, and chemical peels. Make an appointment with one of our board-certified dermatologists who will evaluate your skin and suggest a treatment plan.


Rosacea is a chronic redness of the skin which generally is visible across the cheeks, nose, or forehead, but can also affect the neck, chest, ears, and scalp. In some cases, there may be additional symptoms including small bumps, burning and stinging sensations, even a swollen, red nose.


Warts usually are small, rough growths, typically on hands and feet, which resemble blisters. They are caused by viral infections and they are contagious. They typically disappear after a few months but can last for years and can recur.


Dermatitis is a skin rash which may appear swollen, or red and be itchy. It may be caused by an infection, allergic reaction or exposure to some irritating substance such as detergents, soaps, cleaners, waxes, and chemicals. These substances can wear down the oily, protective layer on the skin’s surface and lead to irritant contact dermatitis.

Dermatitis can be treated with topical creams, cortisone, antihistamines or oatmeal baths.

Skin Tags

Skin tags look like tiny bits of hanging skin and typically occur in sites where clothing rubs against the skin. They develop with age and affect about 25% of the population.

Skin tags can be removed during an in-office procedure if they are irritating to the patient.

Skin Cancer Detection

Skin cancer develops mainly on areas of skin exposed to a lot of sun, most commonly the scalp, face, lips, ears, neck, chest, legs, arms and hands. Some skin cancers appear as small growths or as sores which bleed, scab over, heal and reopen. With melanoma, an existing mole may change or a new, suspicious-looking mole may develop. Melanoma can form in areas not normally exposed to sunlight, such as the scalp, breasts, genitals, and the palms of the hands or the soles of the feet. Malignant melanoma is the deadliest form of skin cancer.

Early detection and treatment of skin cancer can save your life. Make an appointment to see your dermatologist if you notice a new skin growth, a change in the appearance or texture of a mole, or a sore that doesn't heal within two weeks.

Conveniently Located
News & Information
  • 6 Things People of Color Need to Know About Psoriasis (

    We know that more than eight million Americans have psoriasis, but what do the numbers look like when you break it down by race? And how important is it that we do take race into account in the ...

    Read Full Article
  • HS Scar Prevention Secrets That Really Work (

    Dr. Adam Friedman , Professor and Interim Chair of the Department of Dermatology at The GW Medical Faculty Associates, and Dr. Pooja Sodha , Director of the GW Laser Center , provide ...

    Read Full Article

Clinical Trials

  • Prurigo Nodularis (Chronic Prurigo)
    This study is a 12-month, observational, non-interventional study assessing biomarkers, clinical outcomes, and treatment-responsiveness in patients with prurigo nodularis (PN).Patients must be 18 years or older with a confirmed diagnosis of PN (with predominantly nodular disease) by the PI. They must be able to read and understand the consent form and outcomes questionnaires and willing and able to sign the consent form. A separate consent form will be used for genomics testing, which is encouraged for all study participants but not required. Lastly, patients must be willing to participate in the following study-related activities:1) Completion of outcome questionnaires2) Actigraphy data collection3) Biomarker collection by blood draws at each monthly study visit4) Skin biopsy collection5) Medical photography (8-24 photos taken each visit)
  • Photodynamic Therapy for Papulopustular Rosacea
    Dermatology at The GW Medical Faculty Associates is conducting an experimental research study to examine the efficacy of 5-aminolevulinic acid photodynamic therapy (5-ALA PDT) in treating rosacea. The purpose of this study is to evaluate if using 5-ALA PDT improves rosacea symptoms. We are seeking individuals with rosacea between the ages of 18 and 79 to volunteer to participate in this study. This study will take a total of six months (six total visits to the MFA). Prior to each visit, you will be examined and fill out a questionnaire. Participation in the study will be of no direct cost to you. If you are interested in participating in this research study, please contact Dermatology atThe GW Medical Faculty Associates.
    The goal of this study is to evaluate the safety and efficacy of lebrikizumab compared with placebo in patients with moderate-to-severe atopic dermatitis (AD). The dose-response of lebrikizumab in patients will also be measured. Patients with moderate-to-severe AD will be enrolled into this 32-week study. Patients will be seen every 2 weeks, will receive all study drug injections in the clinic, and be evaluated for safety and efficacy through Week 16. A safety follow-up visit will occur at Week 24 and a follow-up phone call will occur at Week 32.
  • A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients with Moderate to Severe Atopic Dermatitis
    The goal of this study is to evaluate the efficacy and safety of baricitinib 1-mg daily and 2-mg daily in comparison to placebo in adult patients with moderate to severe atopic dermatitis. The study is divided into 3 periods: a 5-week Screening Period, a 104-week Double-Blinded Treatment Period, and a 4-week Post-Treatment Follow-Up Period.
  • A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects with Active Cutaneous Lupus Erythematosus.
    The goal of this study is to evaluate the efficacy of BIIB059 in reducing disease activity in subjects with active cutaneous lupus erythematosus (CLE). The subject screening period will last up to 4 weeks. This will be followed by a treatment period of 16 weeks, with subjects randomized to 1 of 4 possible arms, all which will receive monthly treatments given in the office. Two groups will receive BIIB059 and two groups will receive the placebo. The following safety follow-up period will consist of 12 weeks of monthly visits.
  • Topical collagen powder as a wound healing adjuvant for acute full-thickness punch biopsy-induced human wounds: a pilot study
    The GW Medical Faculty Associates Department of Dermatology is conducting an experimental research study to assess collagen powder in treating acute wounds. The purpose of this study is to see if Nuvagen‚Ñ¢ (collagen powder) is effective in treating skin punch biopsy wounds. We are seeking healthy individuals between ages 18-75 to volunteer to participate in this study. The study will take a total of 12 weeks, including 6 total visits to the dermatology clinic. You will receive 1 punch biopsy on each thigh at the 1st and 4th visits. You will also be asked questions about your medical history, answer surveys, and have photographs taken. Participation in the study will be of no direct cost to you.